Home > Healthcare > Drug Device Combination > Drug Coated Devices > Nanomedicine Market

Nanomedicine Market Share

Report ID: GMI5909
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Nanomedicine Market Share

Some of the major market players operating in the nanomedicine market are:

Sanofi SA
Celgene Corporation
Nanobiotix
Luminex Corporation
Nanospectra Biosciences Inc
NanoCarrier Co. Ltd
Johnson & Johnson Services Inc
Merck & Co., Inc
Pfizer, Inc.
NanoCarrier Co. Ltd
Taiwan Liposome Company Ltd
Hoffmann-La Roche AG (Roche)
Gilead Science Inc
Ipsen SA.

These players focus on strategic partnerships, new application launch & commercialization for market expansion.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for nanomedicine recorded USD 210.3 million in 2022 and will showcase 11% CAGR from 2023-2032 due to the increasing advancements and commercialization of technologies, including mRNA and liposome-based vaccines.

The drug delivery application segment held 35.9% of the market share in 2022 driven by the higher need to ensure better drug stability and bioavailability.

Nanomedicine industry share from the oncology indication segment is expected to witness 11.5% CAGR from 2023-2032 due to the increasing incidence of cancer.

North America nanomedicine market size is anticipated to witness 11.3% CAGR from 2023-2032 due to the strong presence of well-defined regulatory framework for the approval and commercialization of medical products.